Identification of Two Flavonoids as New and Safe Inhibitors of Kynurenine Aminotransferase II via Computational and In Vitro Study

Identification of Two Flavonoids as New and Safe Inhibitors of Kynurenine Aminotransferase II via Computational and In Vitro Study

<b>Background/Objectives:</b> Kynurenine aminotransferase II (KAT-II) is a target for treating several diseases characterized by an excess of kynurenic acid (KYNA). Although KAT-II inactivators are available, they often lead to adverse side effects due to their irreversible inhibition me...

Full description

Saved in:

Bibliographic Details
Main Authors:	Redouane Rebai, Luc Jasmin, Abdennacer Boudah
Format:	Article
Language:	English
Published:	MDPI AG 2025-01-01
Series:	Pharmaceuticals
Subjects:	herbacetin (-)-Epicatechin KAT-II inhibition molecular docking molecular dynamics
Online Access:	https://www.mdpi.com/1424-8247/18/1/76
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Resveratrol-Based Carbamates as Selective Butyrylcholinesterase Inhibitors: Design, Synthesis, Computational Study and Biometal Complexation Capability
by: Maja Sviben, et al.
Published: (2025-01-01)

QSAR modelling and docking analysis of some thiazole analogues as alfa-glucosidase inhibitors
by: Muhammad Tukur Ibrahim, et al.
Published: (2019-06-01)

Discovery of novel PRMT1 inhibitors: a combined approach using AI classification model and traditional virtual screening
by: Jungan Zhang, et al.
Published: (2025-01-01)

Naringenin inhibits lipid accumulation by activating the AMPK pathway in vivo and vitro
by: Xiaoyu Cai, et al.
Published: (2023-07-01)

Identification of natural phytochemicals as AKT2 inhibitors using molecular docking and dynamics simulations as potential cancer therapeutics
by: Jibon Kumar Paul, et al.
Published: (2025-01-01)

Using computer modeling to find new LRRK2 inhibitors for parkinson’s disease
by: María C. García, et al.
Published: (2025-02-01)

Evaluation of hesperidin as a potential larvicide against Culex pipiens with computational prediction of its mode of action via molecular docking
by: Abdullah Haikal, et al.
Published: (2025-01-01)

A Theoretical Study on the Efficacy and Mechanism of Combined YAP-1 and PARP-1 Inhibitors in the Treatment of Glioblastoma Multiforme Using Peruvian Maca <i>Lepidium meyenii</i>
by: Albert Gabriel Turpo-Peqqueña, et al.
Published: (2025-01-01)

Identifying natural inhibitors against FUS protein in dementia through machine learning, molecular docking, and dynamics simulation
by: Darwin Li
Published: (2025-02-01)

Identification of musk compounds as inhibitors of the main SARS-CoV-2 protease by molecular docking and molecular dynamics studies
by: Belhassan Assia, et al.
Published: (2024-01-01)

Molecular Docking Study of Caffeic Acid as Acetylcholinesterase Inhibitor
by: Stephanus Satria Wira Waskitha, et al.
Published: (2023-12-01)

Microbial Community, Fatty Acid Composition, and Health Potential of Horse Oil Fermented with Barley Nuruk
by: Jeong-Ha Lee, et al.
Published: (2024-12-01)

Bridging Molecular Docking to Molecular Dynamics to Enlighten Recognition Processes of Tailored D-A/D-A-D Types' AIEgens with HSA/BSA
by: Harun Nalçakan, et al.
Published: (2023-09-01)

Exploring Zinc C295 as a Dual HIV-1 Integrase Inhibitor: From Strand Transfer to 3′-Processing Suppression
by: Sharif Karim Sayyed, et al.
Published: (2024-12-01)

Elucidating the Mechanism of Action of Umami-Enhancing Peptides Derived from Chicken Based on Molecular Simulation
by: ZHANG Jingcheng, HE Wei, LIANG Li, ZHANG Yuyu
Published: (2024-12-01)

Novel tetracycline hybrids: synthesis, characterization, docking studies and in-vitro evaluation of antibacterial activity
by: Mansi Shah, et al.
Published: (2025-01-01)

Screening of SIRT2 inhibitors from natural product databases using computer-aided drug design and molecular dynamics simulation
by: Tianyi Liu, et al.
Published: (2025-01-01)

Natural Product Identification and Molecular Docking Studies of Leishmania Major Pteridine Reductase Inhibitors
by: Moses N. Arthur, et al.
Published: (2024-12-01)

GC–MS analysis and in silico approaches to Stichopus hermanii as anti-inflammatory through PKC-β inhibition
by: Kurnia Fatwati, et al.
Published: (2025-03-01)

Curcumin as a potential inhibitor of TGFβ3 computational insights for breast cancer therapy
by: Ali G. Alkhathami, et al.
Published: (2025-01-01)

Design, synthesis, structural characterization, in vitro anticancer activity, and in silico studies of some new hydroxylated and fluorinated-substituted hydrazone derivatives
by: Reşit Çakmak, et al.
Published: (2025-06-01)

Identification of egg protein-derived peptides as xanthine oxidase inhibitors: virtual hydrolysis, molecular docking, and in vitro activity evaluation
by: Zhipeng Yu, et al.
Published: (2022-11-01)

Computational studies of some benzothiazinone-pepirazine derivatives and lipase b inhibitor for mycobacterium tuberculosis
by: Yakubu Ya'u Muhammad, et al.
Published: (2020-10-01)

Effects of Baicalin on Gout Based on Network Pharmacology, Molecular Docking, and in vitro Experiments
by: Liu C, et al.
Published: (2025-02-01)

Elucidating Molecular Interactions of Natural Inhibitors with HPV-16 E6 Oncoprotein through Docking Analysis
by: Satish Kumar, et al.
Published: (2014-06-01)

Identification of Suitable Natural Inhibitor against Influenza A (H1N1) Neuraminidase Protein by Molecular Docking
by: Maheswata Sahoo, et al.
Published: (2016-09-01)

Anti-melanogenic effects of hydroxyethyl chrysin through the inhibition of tyrosinase activity: In vitro and in silico approaches
by: Yuna Lee, et al.
Published: (2025-01-01)

Telomerase inhibiting phytochemicals derived from Blumea eriantha for cancer treatment: A comprehensive computational analysis
by: Rahil Ummar Faruk Abbu, et al.
Published: (2025-02-01)

In silico (Eco)toxicology and molecular docking of halogenated and oxygenated rotenoid derivatives
by: Damião Sampaio de Sousa, et al.
Published: (2023-12-01)

Curcumin: Synthesis optimization and in silico interaction with cyclin dependent kinase
by: Ahmed Mahmood, et al.
Published: (2017-09-01)

Docking to Explicate Interface between Plant-Originated Inhibitors and E6 Oncogenic Protein of Highly Threatening Human Papillomavirus 18
by: Satish Kumar, et al.
Published: (2015-06-01)

In-silico study of E169G and F242K double mutations in leucine-rich repeats (LRR) polygalacturonase inhibiting protein (PGIP) of Gossypium barbadense and associated defense mechanism against plant pathogens
by: Sneha Murmu, et al.
Published: (2025-01-01)

Deciphering CSU pathogenesis: Network toxicologyand molecular dynamics of DOTP exposure
by: Fang Cao, et al.
Published: (2025-02-01)

Improving the binding affinity of plastic degrading cutinase with polyethylene terephthalate (PET) and polyurethane (PU); an in-silico study
by: Deves Sabari V L, et al.
Published: (2025-01-01)

Structural tailoring of etoricoxib: A spectrochemical, medicinal and pharmacological study
by: Bakul Akter, et al.
Published: (2025-06-01)

Modulatory effects of cinnamomi cortex and its components epicatechin and linalool on skin circadian rhythms
by: Ji-Young Kim, et al.
Published: (2025-02-01)

Identification of New Potential APE1 Inhibitors by Pharmacophore Modeling and Molecular Docking
by: In Won Lee, et al.
Published: (2017-12-01)

Exploring the antiviral potential of shikimic acid against Chikungunya virus through network pharmacology, molecular docking, and in vitro experiments
by: Jialiang Xin, et al.
Published: (2025-01-01)

DockCADD: A streamlined in silico pipeline for the identification of potent ribosomal S6 Kinase 2 (RSK2) inhibitors
by: El Mehdi Karim, et al.
Published: (2025-03-01)

Chemical Profiling Ethyl Acetate Extract of <i>Basilicum polystachyon</i> Leaves and Exploration of Anticancer SIRT1 Inhibitors Using <i>In Silico</i> Approach
by: Tukiran Tukiran, et al.
Published: (2025-01-01)